Chinese HIV Clinical Forum Educational Series 2022

General

Due to unforeseen circumstances, the Chinese HIV Clinical Forum Educational Series 2022 will be converted to a one-day forum. Subscribe to our newsletter to stay updated on the latest developments.

Please contact Ms. Olivia Zhang at olivia.zhang@amededu.com if you need further information or assistance.

The Chinese HIV Clinical Series 2022 will feature lectures on novel treatment strategies. The program is designed to close the most important knowledge gaps in HIV clinical care within Chinese-speaking countries in Asia and beyond. New findings will be presented and discussed within the context of the Asia region, reflecting on the regional and local aspects of the epidemic, national policies, guidelines, and societal context. In addition, clinical cases relevant to Asian healthcare providers will be discussed, which will allow the participants to apply the acquired knowledge to clinical practice.

Program Director

Anton Pozniak, MD, FRCP

Chelsea and Westminster Hospital, United Kingdom

General Information

Who Should Attend?

Primary: Medical doctors involved in the management and treatment of people living with HIV in the region

Secondary: Researchers

Tertiary: Healthcare workers, clinical virologists, microbiologists, scientists, pharmacologists, nurses, post-doctoral researchers, students, and other healthcare professionals involved in the treatment of people living with HIV.

Meeting Objectives

With the HIV Clinical Forum program we aim to:

- Build a community of healthcare professionals devoted to providing optimal clinical care for their patients;

- Create a platform for interactive information exchange on novel treatment options; and

- Translate the latest research achievements into clinical guidance for the optimal management of individuals living with HIV.

Learning Objectives

After participating in the HIV Clinical Forum, participants will be able to:

- Understand the clinical data supporting novel treatment strategies;

- Describe the pros and cons of novel treatment strategies;

- Understand how to integrate novel treatment strategies into routine patient care;

- Be knowledgeable of the clinical data supporting long-acting injectable regimens;

- Identify patients who might best benefit from long-acting injectable regimens;

- Know how best to integrate injectable drugs into routine clinical care;

- Improve their skills in defining and identifying complex HIV patients;

- Stay informed on new drug options for complex patients; and

- Understand how best to use new treatment options in complex HIV patients.

Committees

Program Director

Anton Pozniak, MD, FRCP

Chelsea and Westminster Hospital, United Kingdom

The Program Directors are experts and inspirational leaders in their respective fields. They meet frequently to discuss the scientific program of the meeting, identify interesting topics and candidate speakers, and review all submitted abstracts.

Previous Editions